MDG1:FRA
MediGene AG
€0,017
arrow_upward
+3,61%(+0,00060) 1D
30 Jun., 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
Yahoo Finance
·
2 uur gelede
Goldman Sachs spills the beans on what’s next for S&P 500
WSJ
·
5 uur gelede
U.S. Stocks Rise as AI Bets Offset Bond Yield Fears
Stocktwits
·
2 uur gelede
MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns
Reuters
·
3 uur gelede
Trading Day: Nasdaq highs, Brazil surprise
Profile
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia